|
|
|
Pharma News: Glaxo Falls on Avandia Concerns, Novartis Drug Approved, Icahn to Make Genzyme Board Nominations
February 22, 2010
GlaxoSmithKline (GSK) shares are falling Monday after allegations flew this weekend that the diabetes drug Avandia is unsafe, and could put patients at risk for heart attack. Glaxo shares are trading down 2.53 percent Monday morning.
Copyright (2010) Market News Video.
|
|
|